Andrew D. Moin
Board Member
SAB Biotherapeutics, Inc. (SABS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew D. Moin
Andrew D. Moin is recorded as Board Member at SAB Biotherapeutics, Inc. (SABS). SAB Biotherapeutics, Inc. reported in an 8-K filed October 2, 2023 that Andrew D. Moin was appointed Board of Directors.
“On September 29, 2023, pursuant to the terms of side letter executed with Sessa Capital (Master), L.P., the Company's Board of Directors approved the appointment of Andrew D. Moin, of Sessa Capital (Master), L.P., to the Company's Board of Directors, effective upon the closing of the Offering.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-10-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at SAB Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Samuel J. Reich CEO, Board Member
- David Zaccardelli Chairman, Board Member
- Lucy To CFO
- Mark Conley CFO
- Michael King CFO
- Christoph Bausch COO
- Andrew Moin Board Member
- David Link Board Member
- Dr. Jay S. Skyler Board Member
- Eddie J. Sullivan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.